Feasibility of alternating induction and maintenance chemotherapy in pancreatic cancer

Chemotherapy regimens for pancreatic ductal adenocarcinoma (PDAC) have changed since the introduction of FOLFIRINOX. Due to toxicity, dosage and number of applied cycles are limited. In analogy to chemotherapy strategies in colon cancer we used a scheme of induction, maintenance and re-induction the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hann, Alexander, Bohle, Wolfram, Egger, Jan, Zoller, Wolfram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282479/
https://www.ncbi.nlm.nih.gov/pubmed/28139684
http://dx.doi.org/10.1038/srep41549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282479/
https://www.ncbi.nlm.nih.gov/pubmed/28139684
http://dx.doi.org/10.1038/srep41549

Ejemplares similares